Cathepsin B Expression and Laminin Degradation as Factors Influencing Prognosis of Surgically Treated Patients with Lung Adenocarcinoma

Cancer Research

Volumn 54, Issue 23, 1994, Pages 6133-6136

  Inoue, Takashi ^a   Ishida, Teruyoshi ^a   Sugio, Kenji ^a   Sugimachi, Keizo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; LAMININ; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; DIAGNOSTIC VALUE; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CATHEPSIN B; FEMALE; HUMAN; LAMININ; LUNG NEOPLASMS; MALE; MIDDLE AGE; PROGNOSIS; SUPPORT, NON-U.S. GOV'T; SURVIVAL RATE;

EID: 0028113763     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Slone, B.F. and Honn, K.V. Cysteine proteinase and metastasis. Cancer Metastasis Rev. 3: 249-263, 1984.
2. Sheahan, S. Shuja, S. and Murnane, M.J. Cysteine proteinase activities and tumor development in human colorectal carcinoma. Cancer Res. 49: 3809-3814, 1989.
3. Vasishta, A. Baker, P.R. Hopwood, D. Holly, P.M. and Cuschieri, A. Proteinase-like peptidase activities in malignant and non-malignant gastric tissue. Br. J. Surg. 72: 386-388, 1985.
4. Sloane, B.F. Honn, K.V. Sadler, J.G. Turner, W.A. Kimpso, J.J. and Tayer, J.D. Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential, Cancer Res. 42: 980-986, 1982.
5. Terranova, V.P. Liotta, L.A. Russo, R.G. and Martin, G.R. Role of laminin in the attachment and metastasis of murine tumor cell. Cancer Res. 42: 2265-2269, 1982.
6. Nishino, T. Ishida, T. Oka, T. Yasumoto, K. and Sugimachi, K. Prognostic significance of laminin in adenocarcinoma of the lung. J. Surg. Oncol. 43: 214-218, 1990.
7. Kendall, C. Sandarson, P. and Talbot, U. Follicular thyroid tumors: a study of laminin and type IV collagen in basement membrane endothelium. J. Clin. Pathol. (Lond.), 38: 1100-1105, 1985.
8. Isola, B.J. Weitz, Stephen. Visakorpi, T. Kaija, H. Shea, R. Khabbaz, N. and Kallioniemi, O.P. Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer. J. Clin. Oncol. 11: 36-43 1993.
9. Poole, A.R. Tiltman, K.J. Recklies, A.D. and Stoker, T.A.M. Difference in secretion of the proteinase cathepsin B at the edges of human breast carcinomas and fibroadenoma. Nature (Lond.), 273: 545-547, 1978.
10. Watanabe, M. Higashi, T. Hashimoto, M. Tomoda, I. Tominaga, S. Hashimoto, N. Morimoto, S. Yamaguti, Y. Nakatsukasa, S. Kobayashi, M. and Watanabe, A. Elevation of tissue cathepsin B and activities in gastric cancer. Hepato-gastroenter-ology, 34: 120-122, 1987.
11. International Union Against Cancer (UICC). TNM Classification of Malignant Tumors, Ed. 2, pp. 41-45. Geneva, Switzerland: Union International le Contre Cancer, 1982.
12. World Health Organization. The World Health Organization Histological Typing of the Lung Tumors, Ed. 2. Am. Clin. J. Pathol. 77: 123-136, 1982.
13. Hsu, S. M. Raine, L. and Fanger, H. Use of Avidin-biotin-peroxidase complex (ABC) in immunoperoxidase technique: a comparison between ABC and unlabelled antibody (PAP) procedure. J. Histochem. Cytochem. 29: 577-583, 1981.
14. Guesdon, J.L. Ternyick, T. and Avrameas, S. The use of avidin- biotin interaction in immunoenzymatic techniques. J. Histochem. Cytochem. 27: 1131-1139, 1979.
15. Kaplan, E.L. and Meier, P. Non-parametric estimation from incomplete observation. J. Am. Stat. Assoc. 53: 203-224, 1965.
16. Petp, R. Pike, M. C. Armitage, P. Brestlow, N.E. Cox, D.R. Howard, S. V. Mantel, N. McPherson, K. Peto, J. and Smith, P.G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br. J. Cancer, 35: 1-39, 1977.
17. Cox, D.R. Regression models and life tables. J.R. Stat. Soc. (B), 34: 187-220, 1972.
18. Liotta, L.A. Tumor invasion and metastasis: role of the extracellular matrix-Rhoads Memorial Lecture. Cancer Res. 46: 1-7, 1986.
19. Liotta, L.A. Tryggvason, K. Garbisa, S. Hart, I. Fort, CM. and Shafie, S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature (Lond.), 284: 67-68, 1980.
20. Burleigh, M.C. Barret, A.J. and Lazarrus, G.S. Cathepsin B1 alysosomal enzyme that degrades nativecollagen. Biochem. J. 137: 378-398, 1976.
21. Graf, M. Baici, A. and Strauli, P. Histochemical localization of cathepsin B at the invasion front of the V2 carcinoma. Lab. Invest. 45: 587-596, 1981.
22. Lah, T.T. Buck, M.R. Honn, K.V. Crissman, J.D. Rao, N.C. Liotta, L.A. and Sloane, B.F. Degradation of laminin by human tumor cathepsin B. Clin. Exp. Metastasis, 7: 461-468, 1989.
23. Murane, M.J. Sheahan, K. Ozdermili, M. and Shuja, S. Stage-specific increases in cathepsin B messenger RNA content in human colorectal carcinoma. Cancer Res. 51: 1137-1142, 1991.
24. Oka, T. Ishida, T. Nishino, T. and Sugimachi, K. Immunohistochemical evidence of urokinase-type plasminogen activator in primary and metastatic tumors of pulmonary adenocarcinoma. Cancer Res. 51: 3522-3525, 1991.
25. Foster, S.J. Talbot, I.C. Clayton, D.G. and Critchley, D.R. Tumor basement membrane laminin in adenocarcinoma of rectum: a immunohistochemical study of biological and clinical significance. Int. J. Cancer, 37: 813-817, 1986.
26. Ishida, T. Yokoyama, H. Kaneko, S. Sugio, K. and Sugimachi, K. Long term results of operation for non-small cell lung cancer in the elderly. Ann. Thorac. Surg. 50: 919-922.1990.
27. Jarinen, M. Rinne, A. and Hopsu-Havu, V.K. Human cysteines in normal and disease tissues.a review. Acta Histochem. 82: 5-18, 1987.